Early Experience and Lessons Learned Using Implanted Hemodynamic Monitoring in Patients With Fontan Circulation
Journal of the American Heart Association · 19.12.2023 · 12 (24)
DOI: 10.1161/jaha.123.031836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 19.12.2023. Verfasst von William H Marshall und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus OH. Hauptthemen laut MEDLINE: Fontan Procedure, End Stage Liver Disease, Hemodynamic Monitoring, Heart Failure. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background Data on the use of implanted hemodynamic monitoring (IHM) in patients with Fontan circulation are limited. This study reports our experience using the CardioMEMS HF system in adults with Fontan circulation. Methods and Results This single‐center, retrospective study evaluated heart failure hospitalizations, procedural complications, and device‐related complications in patients with Fontan circulation referred for IHM placement (2015–2022). The association of pulmonary artery pressure (by most recent catheterization and median IHM pressure within 30 days of placement) with both death and follow‐up Model for End‐Stage Liver Disease Excluding International Normalized Ratio score were evaluated. Of 18 patients referred for IHM placement, 17 were successful (median age, 30 [range 21–48] years, 6 women). Procedural complications (access site hematomas, pulmonary artery staining) occurred in 3 patients, without device‐related procedural complications. In follow‐up (median, 35 [range, 6–83] months), 1 patient developed a pulmonary embolism (possibly device‐related). Heart failure hospitalizations/year were similar before and after IHM (median, 1 [interquartile range, 0–1.0] versus 0.6 [0–2.3]; P =0.268), though only 46% of heart failure hospitalizations had associated IHM transmissions. IHM pressures were associated with Model for End‐Stage Liver Disease Excluding International Normalized Ratio scores ( R 2 =0.588, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Department of Internal Medicine The Ohio State University Wexner Medical Center Columbus OH.
- Nationwide Children's Hospital, The Heart Center Columbus OH.
ORCID-Profile: William H Marshall, Saurabh Rajpal, May Ling Mah, Aimee K Armstrong, Arash Salavitabar, Curt J Daniels
Zitieren
APA
Marshall, W. H., Rajpal, S., Mah, M. L., Armstrong, A. K., Salavitabar, A., Hickey, J., Metzger, R., Sisk, T., & Daniels, C. J. (2023). Early Experience and Lessons Learned Using Implanted Hemodynamic Monitoring in Patients With Fontan Circulation. Journal of the American Heart Association, 12(24). https://doi.org/10.1161/jaha.123.031836
Vancouver
Marshall WH, Rajpal S, Mah ML, Armstrong AK, Salavitabar A, Hickey J, et al. Early Experience and Lessons Learned Using Implanted Hemodynamic Monitoring in Patients With Fontan Circulation. Journal of the American Heart Association. 2023;12(24). doi:10.1161/jaha.123.031836
BibTeX
@article{Marshall2023,
author = {Marshall, William H and Rajpal, Saurabh and Mah, May Ling and Armstrong, Aimee K and Salavitabar, Arash and Hickey, Jenne and Metzger, Rachel and Sisk, Tracey and Daniels, Curt J},
title = {Early Experience and Lessons Learned Using Implanted Hemodynamic Monitoring in Patients With Fontan Circulation},
journal = {Journal of the American Heart Association},
year = {2023},
volume = {12},
number = {24},
doi = {10.1161/jaha.123.031836}
}
EUVIMED